Saturday, July 11, 2026

Drug profile · INN

glecaprevir hydrate/pibrentasvir

glecaprevir hydrate/pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — glecaprevir hydrate/pibrentasvir
Class
Route
Patents
1
Programs
0
Data quality
0.78

Quick answer

glecaprevir hydrate/pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN glecaprevir hydrate/pibrentasvir
Brand MAVIRET

Approval history

Authority Status Date
PMDA approved

Related patents

  1. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is glecaprevir hydrate/pibrentasvir?

glecaprevir hydrate/pibrentasvir (MAVIRET) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for glecaprevir hydrate/pibrentasvir?

MAVIRET is a marketed brand name for glecaprevir hydrate/pibrentasvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.